Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancer

Hepato-Gastroenterology

Volumn 48, Issue 39, 2001, Pages 859-863

  Ohara, K ^a   Tatsuzaki, H ^a   Molotkova, N G ^a   Oda, T ^a   Yuzawa, K ^a   Saida, Y ^a   Matsuzaki, Y ^a   Shimizu, W ^a   Todoroki, T ^a   Fukao, K ^a   Tanaka, N ^a   Itai, Y ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Metastasis prediction; Tumor control; Tumor response

Indexed keywords

CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LAPAROTOMY; MALE; METASTASIS; PANCREAS CANCER; PANCREAS RESECTION; PATIENT MONITORING; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT FAILURE;

ADULT; AGED; CA-19-9 ANTIGEN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PANCREATECTOMY; PANCREATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034937881     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Patterns of failure after curative resection of pancreatic cancer
2. Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973
3. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection
4. Preoperative irradiation in carcinoma of the pancreas
5. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas
6. Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head?
7. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group Study
8. Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505
9. Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: Correlations of a clinical trial
10. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer
11. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreas head
12. Clinical benefit response of concurrent chemoradiotherapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer
13. Chemo-radiotherapy for localized pancreatic cancer: Increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-Fluorouracil
14. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
15. Evaluation of the utility of a radioimmunoassay for serum CA 19-9 levels in patients before and after treatment of carcinoma of the pancreas
16. Prognostic value of CA 19-9 levels in patients with carcinoma of the pancreas treated with radiotherapy
17. Extra-hepatic cholestasis determines a reversible increase of glycoprotein tumor markers in benign and malignant diseases
18. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma
19. CA 19-9 serum course and prognosis of pancreatic cancer
20. Prognostic value of serum CA 19-9 levels in pancreatic adenocarcinoma
21. CA 19-9 as a prognostic index after resection for pancreatic cancer
22. CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer